FDA Delays PMTA Review for Popular E-Cigarettes until 2023

Jan.29.2023

FDA says PMTA review for popular e-cigarettes may not be completed until 2023. Deadline has been delayed for half a year.

In a court filing this week, the US Food and Drug Administration (FDA) stated that the review process for premarket tobacco product applications (PMTAs) for some of the most popular electronic cigarettes on the market may not be completed until December 31, 2023.

Earlier, at the 2022 Global Tobacco and Nicotine Forum (GTNF), Brian A. King, director of the Center for Tobacco Products (CTP) at the U.S. Food and Drug Administration (FDA), promised that the CTP would finish the remaining portion of 6.7 million applications by mid-2023. However, according to the latest information, the timeline for completing all application approvals will be delayed by six months.

The court initially set a deadline of September 9, 2021 for the completion of pre-market tobacco product applications (PMTAs) for electronic cigarettes. However, this deadline has now been exceeded by 16 months.

2FIRSTS will continue to follow this issue and report on it in the upcoming month as we engage in a dialogue with the FDA concerning the future of electronic cigarettes in the United States. Stay tuned for updates.

#Europe #Legislation #Open system e-cigarettes #France #FDA #E-cigarette #E-cigarettes and Tobacco

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

U.S. Lawmakers Seek to Empower HHS to Destroy Counterfeit Chinese Tobacco Products

Bipartisan members of the U.S. Congress have introduced the “Ensuring the Necessary Destruction of Illicit Chinese Tobacco Act” (END Act), seeking to amend the Federal Food, Drug, and Cosmetic Act to authorize the Department of Health and Human Services (HHS) to directly destroy adulterated, misbranded, or counterfeit imported tobacco products.Major tobacco companies, including Altria, along with several public health organizations, have announced their support for the bill.

Nov.11 by 2FIRSTS.ai

HSSP INTL signs agreement with COTY to expand e-cigarette business in Middle East and Australia

HSSP INTL(03626.HK) partners with COTY to establish e-cigarette venture in UAE, expand distribution of Heaven Gifts brand.

Oct.30 by 2FIRSTS.ai

Mexico’s Congress Prepares Total Ban on Vapes and E-Cigarettes

Mexico’s Chamber of Deputies is preparing to vote on several major bills before the end of the legislative session, including a full ban on vapes and e-cigarettes. The proposed reform to the General Health Law would prohibit the manufacturing, sale, import, and export of these products, imposing penalties of up to eight years in prison and fines exceeding 200,000 pesos (approximately USD 11,000). L

Dec.09 by 2FIRSTS.ai

Philip Morris Korea Launches New TEREA Packaging for IQOS ILUMA to Mark Third Anniversary

Philip Morris Korea has announced a new packaging design for TEREA, the dedicated tobacco stick brand for its heat-not-burn device IQOS ILUMA, to celebrate the third anniversary of its launch in South Korea. The newly designed products are now available at nine IQOS flagship stores and major convenience stores across the country.

Nov.13 by 2FIRSTS.ai